Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
Hewitt, David J, Aurora, Sheena K, Dodick, David W, Goadsby, Peter J, Ge, Yang (Joy), Bachman, Robert, Taraborelli, Donna, Fan, Xiaoyin, Assaid, Christopher, Lines, Christopher, Ho, Tony W
Published in Cephalalgia (01.04.2011)
Published in Cephalalgia (01.04.2011)
Get full text
Journal Article
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Voss, Tiffini, Lipton, Richard B, Dodick, David W, Dupre, Nicole, Ge, Joy Yang, Bachman, Robert, Assaid, Christopher, Aurora, Sheena K, Michelson, David
Published in Cephalalgia (01.08.2016)
Published in Cephalalgia (01.08.2016)
Get full text
Journal Article
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine
Ho, Tony W, Ho, Andrew P, Ge, Yang (Joy), Assaid, Christopher, Gottwald, Regina, MacGregor, E Anne, Mannix, Lisa K, van Oosterhout, Willebrordus PJ, Koppenhaver, Janelle, Lines, Christopher, Ferrari, Michel D, Michelson, David
Published in Cephalalgia (01.02.2016)
Published in Cephalalgia (01.02.2016)
Get full text
Journal Article
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study
Cho, Byoung Chul, Braña, Irene, Cirauqui, Beatriz, Aksoy, Sercan, Couture, Felix, Hong, Ruey-Long, Miller, Jr, Wilson H, Chaves-Conde, Manuel, Teixeira, Margarida, Leopold, Lance, Munteanu, Mihaela, Ge, Joy Yang, Swaby, Ramona F, Hughes, Brett G M
Published in BMC cancer (25.07.2024)
Published in BMC cancer (25.07.2024)
Get full text
Journal Article
A Two-Stage Adaptive Design in Phase 2 Clinical Trials for Acute Treatment of Migraine
Fan, Xiaoyin (Frank), Assaid, Chris A., Ge, Yang (Joy), Ho, Tony W. H.
Published in Drug information journal (01.05.2011)
Published in Drug information journal (01.05.2011)
Get full text
Journal Article
Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma: The phase 3 KEYNOTE-412 study
Machiels, Jean-Pascal H., Licitra, Lisa F., Tao, Yungan, Yen, Chia-Jui, Rischin, Danny, Waldron, John, Burtness, Barbara, Gregoire, Vincent, Agarwala, Sanjiv S., Yorio, Jeffrey, Delord, Jean-Pierre, Aksoy, Sercan, Ikeda, Sadakatsu, Hong, Ruey-Long, Ge, Joy Yang, Brown, Holly M., Bidadi, Behzad, Siu, Lillian L.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Phase 1 study of pembrolizumab (pembro; MK-3475) plus ipilimumab (IPI) as second-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 cohort D
Patnaik, Amita, Socinski, Mark A., Gubens, Matthew A., Gandhi, Leena, Stevenson, James, Bachman, Robert D., Bourque, Jennifer, Yang Ge, Joy, Im, Ellie, Gadgeel, Shirish M.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Abstract LB-138: Adjuvant pembrolizumab or placebo in patients with high-risk, locally advanced cutaneous squamous cell carcinoma: Phase 3 KEYNOTE-630
Chang, Anne Lynne S., Daniels, Gregory A., Cohen, Ezra E., Ge, Joy Yang, Gumuscu, Burak, Swaby, Ramona F., Geiger, Jessica L.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
KEYNOTE-630: Phase 3 study of adjuvant pembrolizumab versus placebo in patients with high-risk, locally advanced cutaneous squamous cell carcinoma
Geiger, Jessica Lyn, Daniels, Gregory A., Cohen, Ezra E.W., Ge, Joy Yang, Gumuscu, Burak, Swaby, Ramona F., Chang, Anne Lynn S.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Abstract CT285: KEYNOTE-689: A phase 3 study of neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)
Lee, Nancy Y., Uppaluri, Ravindra, Westra, William, Cohen, Ezra E., Haddad, Robert I., Temam, Stephane, Le Tourneau, Christophe, Chernock, Rebecca, Safina, Sufia, Klochikhin, Arkadiy, Meirovitz, Amichay, Brana, Irene, Ge, Joy Yang, Swaby, Ramona F., Pinheiro, Cecilia, Adkins, Douglas
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
A phase 3, randomized, open-label study of epacadostat plus pembrolizumab, pembrolizumab monotherapy, and the EXTREME regimen as first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma (R/M SCCHN): ECHO-304/KEYNOTE-669
Cohen, Ezra E.W., Rischin, Danny, Pfister, David G., Vermorken, Jan Baptist, Zhao, Yufan, Gowda, Hema, Ge, Joy Yang, Jin, Fan, Harrington, Kevin J.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
KEYNOTE-689: Phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma
Uppaluri, Ravindra, Lee, Nancy Y., Westra, William, Cohen, Ezra E.W., Haddad, Robert I., Temam, Stephane, Le Tourneau, Christophe, Chernock, Rebecca, Safina, Sufia, Klochikhin, Arkadiy, Meirovitz, Amichay, Braña, Irene, Ge, Joy Yang, Swaby, Ramona F., Bidadi, Behzad, Adkins, Douglas
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Abstract CT163: KEYNOTE-412: Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma
Siu, Lillian L., Licitra, Lisa, Tao, Yun Gan, Yen, Chia-Jui, Rischin, Danny, Waldron, John, Burtness, Barbara, Gregoire, Vincent, Agarwala, Sanjiv, Yorio, Jeffrey, DeLord, Jean-Pierre, Aksoy, Sercan, Ikeda, Sadakatsu, Hong, Ruey-Long, Ge, Joy Yang, Brown, Holly, Bidadi, Behzad, Machiels, Jean-Pascal
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Pembrolizumab (pembro) plus chemotherapy as front-line therapy for advanced NSCLC: KEYNOTE-021 cohorts A-C
Gadgeel, Shirish M., Stevenson, James, Langer, Corey J., Gandhi, Leena, Borghaei, Hossein, Patnaik, Amita, Villaruz, Liza Cosca, Gubens, Matthew A., Hauke, Ralph J., Yang, James Chih-Hsin, Sequist, Lecia V., Bachman, Robert D., Ge, Joy Yang, Raftopoulos, Harry, Papadimitrakopoulou, Vassiliki
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Pembrolizumab in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): Final efficacy and safety analysis
Mateos, María-Victoria, Orlowski, Robert Z., Siegel, David Samuel DiCapua, Reece, Donna Ellen, Moreau, Philippe, Ocio, Enrique M., Shah, Jatin J., Rodríguez-Otero, Paula, Munshi, Nikhil C., Avigan, David, Ge, Joy Yang, Marinello, Patricia Maria, San Miguel, Jesus
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase I/II study of pembrolizumab (pembro) plus ipilimumab (ipi) as second-line therapy for NSCLC: KEYNOTE-021 cohorts D and H
Gubens, Matthew A., Sequist, Lecia V., Stevenson, James, Powell, Steven Francis, Villaruz, Liza Cosca, Gadgeel, Shirish M., Langer, Corey J., Patnaik, Amita, Borghaei, Hossein, Jalal, Shadia Ibrahim, Fiore, Joseph, Ge, Joy Yang, Raftopoulos, Harry, Gandhi, Leena
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
First-line carboplatin and pemetrexed (CP) with or without pembrolizumab (pembro) for advanced nonsquamous NSCLC: Updated results of KEYNOTE-021 cohort G
Papadimitrakopoulou, Vassiliki, Gadgeel, Shirish M., Borghaei, Hossein, Gandhi, Leena, Patnaik, Amita, Powell, Steven Francis, Gentzler, Ryan D., Martins, Renato G., Stevenson, James, Jalal, Shadia Ibrahim, Panwalkar, Amit W., Yang, James Chih-Hsin, Gubens, Matthew A., Sequist, Lecia V., Awad, Mark M., Fiore, Joseph, Ge, Joy Yang, Raftopoulos, Harry, Langer, Corey J.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Pembrolizumab (pembro; MK-3475) plus platinum doublet chemotherapy (PDC) as front-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 Cohorts A and C
Papadimitrakopoulou, Vassiliki, Patnaik, Amita, Borghaei, Hossein, Stevenson, James, Gandhi, Leena, Gubens, Matthew A., Yang, James Chih-Hsin, Sequist, Lecia V., Yang Ge, Joy, Bourque, Jennifer, Bachman, Robert D., Im, Ellie, Gadgeel, Shirish M.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article